Works matching AU Zhirov, I. V.

Results: 4

Dynamics of the Levels of Interleukin 6, Its Soluble Receptor, and Soluble Glycoprotein 130 in Patients with Chronic Heart Failure and Preserved or Reduced Ejection Fraction.
Published in:
Bulletin of Experimental Biology & Medicine, 2023, v. 174, n. 5, p. 666, doi. 10.1007/s10517-023-05765-7
By:
- Korotaeva, A. A.;
- Samoilova, E. V.;
- Zhirov, I. V.;
- Mindzaev, D. R.;
- Nasonova, S. N.;
- Tereschenko, S. N.
Publication type:
Article
Meprin A in Patients with Acute Decompensation of Heart Failure.
Published in:
Bulletin of Experimental Biology & Medicine, 2022, v. 174, n. 1, p. 26, doi. 10.1007/s10517-022-05641-w
By:
- Samoilova, Е. V.;
- Chepurnova, D. A.;
- Zhirov, I. V.;
- Korotaeva, А. А.
Publication type:
Article
Pathological Remodeling of the Myocardium in Chronic Heart Failure: Role of PGC-1α.
Published in:
Bulletin of Experimental Biology & Medicine, 2018, v. 164, n. 6, p. 794, doi. 10.1007/s10517-018-4082-1
By:
- Kulikova, T. G.;
- Stepanova, O. V.;
- Voronova, A. D.;
- Valikhov, M. P.;
- Sirotkin, V. N.;
- Zhirov, I. V.;
- Tereshchenko, S. N.;
- Masenko, V. P.;
- Samko, A. N.;
- Sukhikh, G. T.
Publication type:
Article
«SGLT2 INHIBITORS: RATIONALE FOR THE USE IN HEART FAILURE», RESOLUTION ON THE RESULTS OF THE PANEL OF EXPERTS WITH INTERNATIONAL PARTICIPATION, ALMATY.
Published in:
Interdisciplinary Approaches to Medicine, 2022, v. 3, n. 2, p. 38, doi. 10.26577/IAM.2022.v3.i2.08
By:
- Abzaliyeva, S. A.;
- Junusbekova, G. A.;
- Zhirov, I. V.;
- Zhusupova, G. K.;
- Abzaliyev, K. B.;
- Tundybaeva, M. K.;
- Bazarbekova, R. B.;
- Raisova, A. M.;
- Babenko, A. Yu.;
- Ionin, V. A.
Publication type:
Article

Works matching AU Zhirov, I. V.

Dynamics of the Levels of Interleukin 6, Its Soluble Receptor, and Soluble Glycoprotein 130 in Patients with Chronic Heart Failure and Preserved or Reduced Ejection Fraction.

Meprin A in Patients with Acute Decompensation of Heart Failure.

Pathological Remodeling of the Myocardium in Chronic Heart Failure: Role of PGC-1α.

«SGLT2 INHIBITORS: RATIONALE FOR THE USE IN HEART FAILURE», RESOLUTION ON THE RESULTS OF THE PANEL OF EXPERTS WITH INTERNATIONAL PARTICIPATION, ALMATY.